SCHEMBL984431

SCHEMBL984431

c1ccc2c(c1)[nH]c1c(-c3ccc(N(c4ccc(-c5cccc6c5[nH]c5ccccc56)cc4)c4ccc(-c5cccc6c5[nH]c5ccccc56)cc4)cc3)cccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.47
PARP14 Q460N5 12/20 0.46
BCHE P06276 1/20 0.43
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
GABRE P78334 1/20 0.42
GABRA6 Q16445 1/20 0.42
GABRG1 Q8N1C3 1/20 0.42
GABRG3 Q99928 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29425587 1.00 KIF11 (0.47) KIF11PARP14BCHECDK4CCND1
SCHEMBL4579999 0.97 KIF11 (0.45) KIF11PARP14BCHECDK4CCND1
SCHEMBL4578609 0.97 KIF11 (0.45) KIF11PARP14BCHECDK4CCND1
SCHEMBL16382430 0.97 CDK4 (0.47) KIF11PARP14BCHECDK4CCND1
SCHEMBL18310312 0.97 KIF11 (0.45) KIF11PARP14BCHECDK4CCND1
SCHEMBL27194803 0.93 TDO2 (0.51) KIF11PARP14CDK4CCND1ALDH1A1
SCHEMBL38828 0.89 KIF11 (0.57) KIF11PARP14BCHECDK4CCND1
SCHEMBL1326376 0.89 KIF11 (0.57) KIF11PARP14BCHECDK4CCND1
SCHEMBL29407801 0.89 KIF11 (0.57) KIF11PARP14BCHECDK4CCND1
SCHEMBL30641449 0.89 KIF11 (0.57) KIF11PARP14BCHECDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194591-A1 ORGANIC LIGHT-EMITTING DIODE (OLED) DISPLAY PANEL, ELECTRONIC DEVICE AND MANUFACTURING METHOD Shanghai Tianma AM-OLED Co., Ltd. (CN) 2017-07-06 US claimed
EP-2041818-B1 LIGHT EMITTING DEVICE CONTAINING PHOSPHORESCENT COMPLEX GLOBAL OLED TECHNOLOGY LLC (US) 2015-06-03 EP claimed
US-8557398-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2013-10-15 US claimed
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US claimed
EP-2286474-A2 METHOD OF MAKING AN OLED Merck Patent GmbH (DE) 2011-02-23 EP claimed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US claimed
EP-2250151-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES Merck Patent GmbH (DE) 2010-11-17 EP claimed
US-7718276-B2 specific compounds useful in light emitting layer e.g. 9,9'-[1,1'-biphenyl]-4,4'-diylbis-9H-carbazole (CBP); 2,2',2''-(1,3,5-phenylene)tris(1-phenyl-1H-benzimidazole) (TPBI) and 4,4',4''-tris(carbazolyl)-triphenylamine (TCTA);4,4',4''-tris[(3-methylphenyl)phenylamino]triphenylamine (MTDATA); GLOBAL OLED TECHNOLOGY LLC (US) 2010-05-18 US claimed
WO-2009149860-A2 METHOD OF MAKING AN OLED MERCK PATENT GMBH (DE) 2009-12-17 WO claimed
WO-2009112854-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH (DE) 2009-09-17 WO claimed
EP-2041818-A2 LIGHT EMITTING DEVICE CONTAINING PHOSPHORESCENT COMPLEX EASTMAN KODAK COMPANY (US) 2009-04-01 EP claimed
WO-2008010915-A2 LIGHT EMITTING DEVICE CONTAINING PHOSPHORESCENT COMPLEX EASTMAN KODAK COMPANY (US) 2008-01-24 WO claimed
US-20080020237-A1 iridium or platinum complex with nitrogen and ester-containing tricyclic ring such as 6-oxo-2-benzopyrano(4,3-b)pyridine; phosphorescent dopants for improved device drive voltage, luminance, efficiency, and lifetime. GLOBAL OLED TECHNOLOGY LLC 2008-01-24 US claimed
US-20080020234-A1 Light emitting device containing phosphorescent complex EASTMAN KODAK COMPANY 2008-01-24 US claimed
US-12595257-B2 Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device LG DISPLAY CO., LTD. (KR) 2026-04-07 US disclosed
US-20260082767-A1 ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, AND ORGANIC THIN FILM TRANSISTOR NIPPON HOSO KYOKAI (JP) 2026-03-19 US disclosed
EP-4660180-A1 IONIC COMPOUND, HOLE TRANSPORT MATERIAL CONTAINING IONIC COMPOUND, PEROVSKITE SOLAR CELL CONTAINING HOLE TRANSPORT MATERIAL, METHOD FOR PRODUCING IONIC COMPOUND, METHOD FOR PRODUCING HOLE TRANSPORT MATERIAL, AND METHOD FOR PRODUCING PEROVSKITE SOLAR CELL National Institute Of Advanced Industrial Science and Technology (JP) 2025-12-10 EP disclosed
US-20060134461-A1 Organometallic materials and electroluminescent devices EASTMAN KODAK COMPANY 2006-06-22 US disclosed
EP-1202608-B1 Organic light-emitting devices TOYOTA CHUO KENKYUSHO KK (JP) 2005-06-15 EP disclosed
EP-1202608-A2 Organic light-emitting devices Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2002-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595257-B2 Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device C1R, CBR1, HCRTR2 KIF11 4465/4885PARP14 1956/4885BCHE 1943/4885
US-20080020237-A1 iridium or platinum complex with nitrogen and ester-containing tricyclic ring such as 6-oxo-2-benzopyrano(4,3-b)pyridine; phosphorescent dopants for improved device drive voltage, luminance, efficiency, and lifetime. OCIAD1, OCIAD2, OXER1 KIF11 3531/4885PARP14 1359/4885BCHE 2756/4885
US-20260082767-A1 ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, AND ORGANIC THIN FILM TRANSISTOR L1CAM, EML4, EPCAM KIF11 2197/4885PARP14 4782/4885BCHE 3329/4885
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES NR2E3, NR4A2, NR4A3 KIF11 1667/4885PARP14 1212/4885BCHE 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.